13-110195219-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.1286-101G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0887 in 945,432 control chromosomes in the GnomAD database, including 4,770 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1451 hom., cov: 32)
Exomes 𝑓: 0.083 ( 3319 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.17

Publications

2 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 13-110195219-C-T is Benign according to our data. Variant chr13-110195219-C-T is described in ClinVar as Benign. ClinVar VariationId is 1293369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.1286-101G>A intron_variant Intron 21 of 51 ENST00000375820.10 NP_001836.3
COL4A1NM_001303110.2 linkc.1286-101G>A intron_variant Intron 21 of 24 NP_001290039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.1286-101G>A intron_variant Intron 21 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18201
AN:
152024
Hom.:
1446
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.228
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.0280
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.0698
Gnomad FIN
AF:
0.0573
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0761
Gnomad OTH
AF:
0.101
GnomAD4 exome
AF:
0.0827
AC:
65642
AN:
793290
Hom.:
3319
AF XY:
0.0813
AC XY:
33740
AN XY:
414944
show subpopulations
African (AFR)
AF:
0.231
AC:
4696
AN:
20320
American (AMR)
AF:
0.134
AC:
4887
AN:
36540
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
604
AN:
21456
East Asian (EAS)
AF:
0.150
AC:
5185
AN:
34476
South Asian (SAS)
AF:
0.0706
AC:
4834
AN:
68436
European-Finnish (FIN)
AF:
0.0626
AC:
3153
AN:
50330
Middle Eastern (MID)
AF:
0.0346
AC:
153
AN:
4426
European-Non Finnish (NFE)
AF:
0.0749
AC:
38870
AN:
519266
Other (OTH)
AF:
0.0857
AC:
3260
AN:
38040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3169
6338
9506
12675
15844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
986
1972
2958
3944
4930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18247
AN:
152142
Hom.:
1451
Cov.:
32
AF XY:
0.118
AC XY:
8762
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.229
AC:
9479
AN:
41468
American (AMR)
AF:
0.105
AC:
1609
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
97
AN:
3468
East Asian (EAS)
AF:
0.128
AC:
660
AN:
5168
South Asian (SAS)
AF:
0.0696
AC:
335
AN:
4812
European-Finnish (FIN)
AF:
0.0573
AC:
607
AN:
10600
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0761
AC:
5177
AN:
68016
Other (OTH)
AF:
0.101
AC:
213
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
788
1576
2364
3152
3940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0890
Hom.:
127
Bravo
AF:
0.129
Asia WGS
AF:
0.107
AC:
371
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.76
DANN
Benign
0.43
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9588112; hg19: chr13-110847566; API